The Case for Using Filing Dates Instead of Expiration Dates to Determine Obviousness-Type Double Patenting (Part I)
The judicially-created doctrine of obviousness-type double patenting (ODP) originated long ago as a shield to protect the public against unwarranted patent term extension (PTE).
Breckenridge Pharm Novartis Pharms Gilead Sciences Inc Ezra Ventures Natco Pharma Ltd Trademark Office
Source: ipwatchdog.com